SAB Biotherapeutics, Inc. (SABSW) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $933.2K | +176.7% |
| 2024 | $337.3K | +71.1% |
| 2023 | $197.2K | -90.9% |
| 2022 | $2.17M | -80.2% |
| 2021 | $10.94M | -14.0% |
| 2020 | $12.73M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $933.2K | +176.7% |
| 2024 | $337.3K | +71.1% |
| 2023 | $197.2K | -90.9% |
| 2022 | $2.17M | -80.2% |
| 2021 | $10.94M | -14.0% |
| 2020 | $12.73M | — |